Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote Technologies in Early Stages of Alzheimer's Disease

NCT: NCT07521865 · ACTIVE_NOT_RECRUITING

NCT IDNCT07521865
StatusACTIVE_NOT_RECRUITING
Start Date2023-06-01
Completion2026-04-30

Brief Summary

The investigators are adapting a tablet-based cognitive training program for Alzheimer's disease (AD) by focusing on specific cognitive components. It is aimed to demonstrate the feasibility, acceptability and usability of remote cognitive training in older adults with Mild Cognitive Impairment (MCI) and AD dementia. The study involves 36 participants in three groups, with a two-week intervention and focus groups for refinement.

Frequently Asked Questions

What is Remote Technologies in Early Stages of Alzheimer's Disease?

Remote Technologies in Early Stages of Alzheimer's Disease is a clinical trial registered under NCT07521865. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07521865?

The current status of NCT07521865 (Remote Technologies in Early Stages of Alzheimer's Disease) is: ACTIVE_NOT_RECRUITING.

When did Remote Technologies in Early Stages of Alzheimer's Disease start?

Remote Technologies in Early Stages of Alzheimer's Disease started on 2023-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑